LAROCHE RICHARD F JR
SEC Form 4 insider trading activity
LAROCHE RICHARD F JR has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.
On the most recent filing, LAROCHE RICHARD F JR is listed as Director at NATIONAL HEALTHCARE CORP. Inside the rolling window, LAROCHE RICHARD F JR reported no open-market purchases and 1 open-market sale totaling $1.5M in NHC.
Companies traded
Other insiders at NHC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has LAROCHE RICHARD F JR made?
LAROCHE RICHARD F JR has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does LAROCHE RICHARD F JR trade?
LAROCHE RICHARD F JR has filed SEC Form 4 disclosures for 1 company, including NHC.
When was LAROCHE RICHARD F JR's most recent SEC Form 4 filing?
LAROCHE RICHARD F JR's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.
What is LAROCHE RICHARD F JR's total buy and sell value in the current window?
Inside the rolling retention window, LAROCHE RICHARD F JR bought $0 and sold $1.5M based on SEC Form 4 filings.
What was LAROCHE RICHARD F JR's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,500 NHC shares on 2026-05-21, worth $1.5M, per SEC Form 4 filings.